investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

Development of covalent PIP4K2 inhibitors for the treatment of p53 deficient lung tumors

Nathanael Schiander Gray

0 Collaborator(s)

Funding source

National Institutes of Health (NIH)

Related projects

Martin Mcintosh

Profiling cancer neoantigen repertoires and validating immunotherapy targets

Trachea, bronchus and lung

Claudia Palena

Novel Targets for Vaccine Therapy

Trachea, bronchus and lung

Alexander D Sorkin

Pathogenesis of Cancer: Role of EGF Receptor Endocytosis

Trachea, bronchus and lung

Pathology

Allan Weissman

Determining the Fate of Transmembrane Proteins

Trachea, bronchus and lung

Peter S Hammerman

Therapeutic targeting of Fibroblast Growth Factor Receptors in Squamous Cancers

Trachea, bronchus and lung

Brid Ryan

Examining the Inverse Relationship Between Parkinson's Disease and Lung Cancer

Trachea, bronchus and lung

Pathology

Michael J Eck

Inhibitor-sensitive and -resistant EGFR mutants from lung cancer and glioblastoma

Trachea, bronchus and lung

Jonathan M Kurie

Regulation of Lung Cancer Metastasis by miR-200

Trachea, bronchus and lung

Curtis Harris

Biomarkers in Cancer Diagnosis, Prognosis, and Therapeutic Outcome

Trachea, bronchus and lung

Pediatric oncology or childhood cancer Pathology